Morbidity and Mortality Weekly Report, December 09, 1983 / 32(48);635-6
As of November 25, 1983, Canada's Laboratory Centre for Disease Control (LCDC) has received reports of 51 cases of AIDS. Patients have ranged in age from 20 to 53 years, with 80% occurring in the 20- to 39-year age group. Forty-four (86%) were males. Forty-nine percent of all patients were homosexuals; however, the number of heterosexual patients (43%) is increasing; most are Haitians, and two are hemophilia patients.
Morbidity and Mortality Weekly Report, December 02, 1983 / 32(47);613-5
In 1982, six hemophilia A patients who had developed Pneumocystis carinii pneumonia (PCP) and other opportunistic infections and who met the CDC case definition of AIDS were reported by CDC (1,2). As of November 30, 1983, physicians and health departments in the United States have reported a total of 21 AIDS cases among hemophilia patients--19 among patients with hemophilia A and two among patients with hemophilia B.
Morbidity and Mortality Weekly Report, November 25, 1983 / 32(46);610-1
The following table (Table 3) summarizes the cases of AIDS reported by member countries of the European Region of the World Health Organization (WHO) as of October 1983 (1,2). Reported by WHO Weekly Epidemiological Record, 1983;58:351.
Morbidity and Mortality Weekly Report, September 09, 1983 / 32(35);465-7
As of September 2, 1983, physicians and health departments in the United States and Puerto Rico had reported 2,259 persons with acquired immunodeficiency syndrome (AIDS) who met the surveillance case definition.* Of these, 917 (41%) are known to have died.
Morbidity and Mortality Weekly Report, September 09, 1983 / 32(35);457-64
Initial epidemiologic studies indicated that the use of inhalant drugs, such as amyl nitrite, isobutyl nitrite (IBN), and butyl nitrite, may be a risk factor for acquired immunodeficiency syndrome (AIDS) (1,2). Because the immunotoxic potential of these drugs was unknown, CDC undertook an immunotoxicologic evaluation of one of the most commercially available inhalants--IBN.
Morbidity and Mortality Weekly Report, September 02, 1983 / 32(34);450-1
Acquired immunodeficiency syndrome (AIDS) was first recognized in 1981. The epidemiology of AIDS is consistent with the hypothesis that it is caused by a transmissible infectious agent (1-3). AIDS appears to be transmitted by intimate sexual contact or by percutaneous inoculation of blood or blood products.
Morbidity and Mortality Weekly Report, August 05, 1983 / 32(30);389-91
Between June 1981 and August 1, 1983, physicians and health departments in the United States and Puerto Rico reported 1,972 cases of acquired immunodeficiency syndrome (AIDS) meeting the surveillance definition*. These cases were diagnosed in patients who have Kaposi's sarcoma (KS) or an opportunistic infection suggestive of an underlying cellular immunodeficiency.
Morbidity and Mortality Weekly Report, July 15, 1983 / 32(27);358-60
As of July 11, 1983, physicians and health departments in the United States and Puerto Rico had reported a total of 1,831 patients meeting the CDC surveillance definition of the acquired immunodeficiency syndrome (AIDS) (1). Of these, four were reported to be health-care personnel not known to belong to groups at increased risk for AIDS.
Morbidity and Mortality Weekly Report, June 24, 1983 / 32(24);309-11
As of June 20, 1983, physicians and health departments in the United States and Puerto Rico had reported a total of 1,641 cases of acquired immunodeficiency syndrome (AIDS). These cases were diagnosed in patients who had Kaposi's sarcoma (KS) or an opportunistic infection suggestive of an underlying cellular immunodeficiency.
Morbidity and Mortality Weekly Report, May 13, 1983 / 32(18);233-4
Recent evidence suggests that human T-cell leukemia virus (HTLV) infection occurs in patients with acquired immune deficiency syndrome (AIDS). HTLV has been isolated from peripheral blood T-lymphocytes from several patients with AIDS (1, 2), and a retrovirus, related to but clearly distinct from HTLV . . . .
Morbidity and Mortality Weekly Report, March 18, 1983 / 32(10);134-6
Since its licensure in 1981 and its general availability in July 1982, hepatitis B virus (HBV) vaccine has been administered to over 200,000 individuals, mostly health care workers. In a collaborative effort, the Centers for Disease Control, the Food and Drug Administration, and Merck, Sharp, and Dohme have collected information on illnesses that developed after receipt of HBV vaccine.
Morbidity and Mortality Weekly Report, March 04, 1983 / 32(8);101-3
Since June 1981, over 1,200 cases of acquired immune deficiency syndrome (AIDS) have been reported to CDC from 34 states, the District of Columbia, and 15 countries. Reported cases of AIDS include persons with Kaposi's sarcoma who are under age 60 years and/or persons with life-threatening opportunistic infections with no known underlying cause for immune deficiency.
Morbidity and Mortality Weekly Report, January 07, 1983 / 31(52);700-1
CDC has received reports from New York and New Jersey of 16 prison inmates with the acquired immune deficiency syndrome (AIDS). New York: Between November 1981 and October 1982, ten AIDS cases (nine with Pneumocystis carinii pneumonia (PCP) and one with Kaposi's sarcoma (KS)) were reported among inmates of New York State correctional facilities.
Morbidity and Mortality Weekly Report, January 07, 1983 / 31(52);697-8
CDC has received reports of two females with cellular immunodeficiency who have been steady sexual partners of males with the acquired immune deficiency syndrome (AIDS).
This information is designed to support, not replace, the relationship that exists between you and your doctor.